Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07234240Not ApplicableCompleted

Blinded Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

Role: lead

NCT06620120Not ApplicableCompleted

Investigate the Effect of EPITACT® Light Legs Therapeutic Insoles on the Symptoms and Quality of Life of Patients With Chronic Venous Disease

Role: lead

NCT06395025Not ApplicableCompleted

Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group

Role: lead

NCT06153680Not ApplicableCompleted

Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return

Role: lead

All 4 trials loaded